Securities code: Jiangxi Sanxin Medtec Co.Ltd(300453) securities abbreviation: Jiangxi Sanxin Medtec Co.Ltd(300453) Announcement No.: 2022009 Jiangxi Sanxin Medtec Co.Ltd(300453)
Announcement on the resolutions of the 16th meeting of the 4th board of supervisors
The company and all members of the board of supervisors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.
Jiangxi Sanxin Medtec Co.Ltd(300453) (hereinafter referred to as “the company”) the notice of the 16th meeting of the 4th board of supervisors was sent by e-mail on March 4, 2022 and held in the company’s conference room at 16:00 p.m. on March 15, 2022. There are 3 supervisors who should attend this meeting, and there are actually 3 supervisors. The meeting was convened by Ms. Yu Zhenzhu, the chairman of the board of supervisors, who presided over the meeting. There are 3 supervisors who should vote at the meeting and 3 supervisors who actually vote. This meeting complies with the company law of the people’s Republic of China, the articles of association and other relevant provisions, and the meeting is legal and valid. After full discussion, the following proposals were considered and adopted:
1、 The proposal on the work report of the board of supervisors in 2021 was deliberated and adopted
In 2021, the board of supervisors of the company supervised the legal operation of the company and the performance of the duties of the directors and senior managers of the company within the scope of powers conferred by the company law and the articles of association, which better protected the shareholders’ rights and interests of the company, the interests of the company and the legitimate rights and interests of employees, and promoted the standardized operation of the company.
For details, please refer to the work report of the board of supervisors in 2021 published by the company on the gem information disclosure website designated by the CSRC on the same day. Please refer to the majority of investors.
Voting results: 3 in favor, 0 against and 0 abstention
2、 Deliberated and passed the proposal on the company’s 2021 annual financial statement report
Voting results: 3 in favor, 0 against and 0 abstention
3、 The proposal on the full text of the company’s 2021 annual report and its abstract was deliberated and adopted
After review, the board of supervisors believes that the procedures for the full text and summary of the company’s 2021 annual report prepared and reviewed by the board of directors comply with laws, administrative regulations and the provisions of the CSRC, and the contents of the report truly, accurately and completely reflect the actual situation of the company, without any false records, misleading statements or major omissions. For details, please refer to the relevant announcements (Announcement No.: 2022011, 2022012) published by the company on the gem information disclosure website designated by the CSRC on the same day.
Voting results: 3 in favor, 0 against and 0 abstention
4、 The proposal on the company’s profit distribution plan for 2021 was reviewed and approved
After review, the board of supervisors believes that the profit distribution plan for 2021 formulated by the board of directors of the company, on the premise of complying with the relevant provisions of the company law, the articles of association and so on, takes into account the company’s financial status and future fund use planning, and organically combines the interests of shareholders with the long-term development of the company. The board of supervisors unanimously agreed to the proposal.
For details, please refer to the relevant announcement (Announcement No.: 2022013) published by the company on the gem information disclosure website designated by the CSRC on the same day.
Voting results: 3 in favor, 0 against and 0 abstention
5、 Deliberated and passed the proposal on the company’s self evaluation report on internal control in 2021
After review, the board of supervisors believes that the company has established a relatively perfect internal control system in accordance with relevant laws and regulations such as the company law, the securities law, the Listing Rules of GEM stocks of Shenzhen Stock Exchange, the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of GEM listed companies, and can be effectively implemented, It ensures the orderly and effective development of the company’s business activities. The company’s self-evaluation report on internal control in 2021 truly and objectively reflects the construction and operation of the company’s internal control system.
For details, please refer to the 2021 internal control self-evaluation report published by the company on the gem information disclosure website designated by the CSRC on the same day. Please refer to the majority of investors.
Voting results: 3 in favor, 0 against and 0 abstention
6、 The proposal on the review report on the occupation of funds by the company’s controlling shareholders and other related parties in 2021 was reviewed and approved
After examination, the board of supervisors held that the occupation of the company’s funds by related parties reflected in the audit report on the occupation of funds by Jiangxi Sanxin Medtec Co.Ltd(300453) controlling shareholders and other related parties issued by Daxin Certified Public Accountants (special general partnership) is a normal business transaction, and there is no illegal occupation of funds by controlling shareholders and other related parties.
For details, please refer to the audit report on the occupation of funds by controlling shareholders and other related parties published on the gem information disclosure website designated by the CSRC on the same day.
Voting results: 3 in favor, 0 against and 0 abstention
7、 The proposal on the renewal of the company’s audit institution in 2022 was deliberated and adopted
After examination, the board of supervisors believes that Daxin Certified Public Accountants (special general partnership) has the audit qualification for securities and futures related businesses approved by the Ministry of Finance and China Securities Regulatory Commission. Since the company hired Daxin Certified Public Accountants (special general partnership) as the audit institution of the company, it has been diligent and conscientious, adhered to a fair and objective attitude to conduct independent audit, and completed various audit work of the company. We agree to renew the appointment of Daxin Certified Public Accountants (special general partnership) as the company’s audit institution in 2022.
For details, please refer to the relevant announcement (Announcement No.: 2022014) published by the company on the gem information disclosure website designated by the CSRC on the same day.
Voting results: 3 in favor, 0 against and 0 abstention
8、 The proposal on the company’s financing plan in 2022 was deliberated and adopted
After review, the board of supervisors believes that the total amount of debt financing of the company and its subsidiaries by applying for loans from banks and other financial institutions and other legal means in 2022 is no more than 500 million yuan, which is conducive to accelerating the company’s capital turnover, improving the efficiency of capital use and meeting the actual needs of the company’s operation and development, It will not bring significant financial risks to the company and damage the interests of the company, and there is no situation that damages the interests of investors. The board of supervisors approved the proposal of the company’s 2022 financing plan.
For details, please refer to the relevant announcement (Announcement No.: 2022015) published by the company on the gem information disclosure website designated by the CSRC on the same day.
Voting results: 3 in favor, 0 against and 0 abstention
9、 Deliberated and adopted the proposal on Amending the rules of procedure of the board of supervisors
In accordance with the latest provisions of relevant laws, regulations and normative documents such as the company law, the securities law, the guidelines for the articles of association of listed companies, the Listing Rules of GEM stocks of Shenzhen Stock Exchange, the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of GEM listed companies, and in combination with the actual situation of the company, The company amended the rules of procedure of the board of supervisors accordingly.
For details, please refer to the rules of procedure of the board of supervisors published by the company on the gem information disclosure website designated by the CSRC on the same day.
Voting results: 3 in favor, 0 against and 0 abstention
10、 The proposal on investing in the construction of R & D and production base of hemodialysis series products was reviewed and approved. After review, the board of supervisors held that the company’s use of its own funds and bank loans of 568 million yuan to build a new “R & D and production base project of hemodialysis series products” is conducive to improving product production capacity and operating performance, and there is no harm to the interests of investors. The board of supervisors agreed to invest in the construction of “R & D and production base project of hemodialysis series products”.
For details, please refer to the relevant announcement (Announcement No.: 2022018) published by the company on the gem information disclosure website designated by the CSRC on the same day.
Voting results: 3 in favor, 0 against and 0 abstention
It is hereby announced
Jiangxi Sanxin Medtec Co.Ltd(300453) board of supervisors
March 17, 2022
